Infectious pneumonia is a severe complication at the early stage of kidney transplantation and is associated with significant mortality in recipients not only in human clinics but also in veterinary medicine \[[@r11], [@r12], [@r22]\]. However, no standard guidelines for managing infectious complications after transplantation have been set in veterinary medicine. Potent immunosuppressants given to prevent host rejection could increase opportunities for microorganism infection and lead to difficulties with treatment \[[@r6]\]. Previous reports in humans have suggested that significantly reducing immunosuppressant doses are extremely important to treat bacterial pneumonia in kidney transplant recipients \[[@r19]\]. Unlike human and feline renal transplant patients, canine recipients require highly aggressive immunosuppressive therapy, because of the intense host response these animals mount against the graft \[[@r9]\]. A previous veterinary report has shown that the death of canine patients can occur due to graft rejection when immunosuppressive drug doses are decreased to control infectious pneumonia \[[@r11]\]. Therefore, it is difficult for veterinarians to decide whether the doses of immunosuppressant reagents should be reduced to treat an infection in a transplant recipient. In this report, we describe a case of pneumonia due to infection with MDR *P. aeruginosa* in a kidney recipient dog during the high-risk period of acute allorejection and the successful treatment of this case without reducing the immunosuppressive medication dose.

An 8-year-old, 6.3 kg, male mongrel dog was referred to Kangwon National University Veterinary Hospital for treatment of end-stage chronic kidney disease. The dog underwent heterotrophic renal transplantation in the iliac fossa with a kidney from a healthy dog leukocyte antigen cross-matched littermate donor. To assess whether a littermate dog is compatible as a kidney donor, blood typing, erythrocyte cross-match and complement-dependent cytotoxic cross-match tests were performed \[[@r14]\]. The transplant recipient also underwent bilateral native nephrectomy and had been given 20 mg/kg microemulsified cyclosporine (Implanta, PO, q24h; Hanmi, Seoul, Korea), 1 mg/kg predinisolone (Solondo, PO, q24h; Yuhanmedica, Ochang, Korea) and 5 mg/kg azathioprine (Immuthera, PO, q48h; Celltrion, Incheon, Korea) as immunosuppressive therapy 2 days prior to transplantation according to a previously described protocol \[[@r14]\]. The cyclosporine trough concentration was maintained approximately 400--700 *n*g/m*l* for the first 6 months after surgery, and then the dosage was reduced to maintain a trough concentration of 250--350 *n*g/m*l* as measured by high-performed liquid chromatography \[[@r3]\]. Prednisolone dose was gradually reduced 1 month after surgery and discontinued after 3 months \[[@r14]\]. We administered 22 mg/kg cefazolin (Cefazolin, IV, q12h; Chong Kun Dang Pharm, Seoul, Korea) for 5 days after surgery as prophylaxis. The dog showed good postoperative recovery. Laboratory evaluation results including complete blood count (CBC), serum biochemistry, urinalysis and ultrasonography were also normal 18 days after transplantation.

Twenty-five days after surgery, the dog was readmitted to the hospital due to acute onset anorexia, frequent coughing and exercise intolerance. Physical examination revealed a body condition score of 4/9, mild exertional dyspnea, increased respiratory rate (36 breaths/min) and fever (39.8°C). Slight crackling lung sounds were also heard during inspiration, but a cardiac murmur was not detected. Laboratory examination including serum chemistry analysis, blood gas analysis, pulse oxymetry, urine examination, excretory urography and ultrasonography did not produce any atypical findings. Lung lobe infiltration and air bronchogram signs with a generalized increase in lung opacity in both the left and right side caudal lobes were viewed on ventrodorsal and right lateral thoracic radiographs ([Fig. 1a and 1b](#fig_001){ref-type="fig"}Fig. 1.Thoracic radiographs of a dog with pneumonia after renal transplantation. Ventrodorsal (a) and right lateral thoracic radiographs (b) were taken 25 days after surgery. Infiltration in the caudal lung lobe and air bronchogram signs (white arrowheads) were observed. Ventrodorsal (c) and right lateral thoracic radiographs (d) were taken 10 days after imipenem-cilastatin administration. Abnormal lung infiltration had disappeared.). CBC test results ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2.White blood cell (WBC) count of a dog with pneumonia during the post-transplantation period. The black arrow indicates the day clinical symptoms of respiratory infection were observed. The white arrow indicates the first day of imipenem-cilastatin administration.) were indicative of neutrophilic leukocytosis (37.0 × 10^3^/*µl*, reference range 4 to 15.5 × 10^3^/*µl*) with a mild left shift (band neutrophils 1.0 × 10^3^/*µl*, reference range 0 to 0.3 × 10^3^/*µl*). Results of a canine distemper polymerase chain reaction (PCR) test (Neodin Vetlab, Seoul, Korea) and heartworm antigen kit test (SNAP^®^ Heartworm RT Test, IDEXX Laboratories Inc., Westbrook, ME, U.S.A.) were negative (data not shown). There was no clinical evidence of renal graft failure or rejection based on the results of CBC, serum chemistry and urinalysis.

We made a provisional diagnosis of bacterial pneumonia based on radiography, CBC and physical examination findings. Empirical treatments were started with a combination of two broad-spectrum antibiotics \[10 mg/kg enrofloxacine (Baytril, SQ, q24h; Bayer Korea, Seoul, Korea) and 22 mg/kg ampicillin-sulbactam (Ucillin, IV, q12h; Dongkoo, Seoul, Korea)\], fluids, nebulizer treatment combined with gentamycin (Gentamycin sulfate, Kukje, Seongnam, Korea) and coupage for 5 days until the final diagnosis was made. We continued immunosuppressive therapy without any dosage reduction due to concerns about the high risk for acute rejection during the early stage of kidney allograft.

A microorganism culture test was performed with tracheal wash fluid, blood and urine from the recipient dog as well as blood and urine from the donor animal. To obtain a tracheal wash specimen, the canine was anesthetized with 5 mg/kg propofol (Provive, Myungmoon, Seoul, Korea). We subsequently inserted an endotracheal tube with a rubber catheter into the trachea, pushed in 5 m*l* of warm saline and immediately withdrew the liquid to collect a sample. Bacterial pneumonia caused by *P. aeruginosa* was confirmed by a microorganism isolation test carried out according to a previous protocol \[[@r18]\]. Test results revealed that the bacterial infection was localized in the respiratory tract. Bacterial cultures of urine and blood from both the recipient and donor were both aerobically and anaerobically negative. Despite administration of broad-spectrum antibiotics (enrofloxacine and ampicillin-sulbactam) for 5 days, clinical symptoms of the recipient dog did not improve.

The *P. aeruginosa* strain isolated from the tracheal washing was sensitive to only imipenem and amikacin, had intermediate susceptibility to gentamycine and polymixinB; and was resistant to ceftazidime, piperacillin and ciprofloxacine. The patient was started on 5 mg/kg imipenem-cilastatin (Imipenem-cilastatin, IV over 30 min, q8h; Yungjin, Goyang, Korea). After 10 days of treatment, the cough and nasal discharge had markedly diminished, and neutrophil counts were in the normal range ([Fig. 2](#fig_002){ref-type="fig"}). Lung lesions observed on thoracic radiographs had clearly improved. ([Fig. 1c and 1d](#fig_001){ref-type="fig"}). Blood urea nitrogen (17--25 mg/d*l*, reference range 5--30 mg/d*l*) and serum creatinine (0.9--1.3 mg/d*l*, reference range 0.7--1.8 mg/d*l*) concentrations were maintained within the reference range during the entire post-transplantation period ([Fig. 3a and 3b](#fig_003){ref-type="fig"}Fig. 3.Blood urea nitrogen (BUN) as well as serum creatinine and cyclosporine trough concentrations was maintained within the reference range during the post-operation period. An arrow indicates the day on which acute onset of clinical signs of pneumonia occurred. *The shaded area indicates the reference range.*). Blood cyclosporine levels did not show any marked changes during the course of anti-pneumonia therapy ([Fig. 3c](#fig_003){ref-type="fig"}). The antibiotic therapy was continued for 1 week, after all symptoms had subsided to prevent recurrent pneumonia. No complications or disease recurrence was observed during the 2-year follow-up period.

Reports of renal transplantation in canines have been sporadically published in veterinary literature \[[@r11]\]. Most of these studies have focused on the effectiveness of immunosuppression protocols, surgical techniques and the survival of the animal recipients \[[@r4], [@r9], [@r17]\]. Although some reports have briefly described successful recovery from bacterial complications that were not due to MDR strains, others have presented cases in which the infections did not respond well to treatment with antimicrobials \[[@r9], [@r11]\]. Infection with multidrug-resistant (MDR) *Pseudomonas (P.) aeruginosa* in kidney transplant recipients leads to life-threatening complication in humans \[[@r16]\]. This condition is difficult to manage due to the limited susceptibility of MDR *P. aeruginosa* to antibiotics \[[@r7], [@r15]\]. To the best of our knowledge, several case reports on this topic have been published in human medicine, but no report has appeared in veterinary medical literature and no standard guidelines for diagnosis or treatment have been established for animal recipients \[[@r15], [@r16], [@r20], [@r23]\].

We performed a tracheal wash to obtain a sample to identify the best antibiotics for the bacteria isolated from the trachea. Cultivation of sputum or blood is not specific and sensitive method to distinguish real pathogen. On the other hand, transbronchial or open lung biopsy is effective for diagnosis, but is associated with high morbidity \[[@r19]\]. In our protocol, the recovery of a patient from anesthesia and tracheal wash procedure was relatively fast, and no complication has occurred. Tracheal wash would be a necessary protocol for early diagnosis of pulmonary infection in the canine transplant patients.

The strong immunosuppressants that are administered to prevent host rejection can increase the risk of bacterial infection, because these reagents impair cell-mediated immunity while reducing T cell and immunoglobulin function. Moreover, neutrophils and alveolar macrophages also become unresponsive to chemoattractants and their phagocytotic activities decrease \[[@r5]\]. In the case presented in this report, we did not reduce the immunosuppressant drug dosage, because sufficient immunosupression is necessary to prevent organ rejection during the early stage of transplantation and reducing the medication dosage could lead to irreversible acute organ rejection and eventual failure.

It is unclear how MDR P. *aeruginosa* pneumonia occurred. We speculate that the MDR P. *aeruginosa* infection in this case was opportunistic or acquired in the hospital. P. *aeruginosa* is an opportunistic human and animal pathogen that can be isolated from the ear canal, skin, nasal cavity and mouth of healthy dogs \[[@r18]\]. *This bacterial strain* is the second most common (17%) cause of nosocomial pneumonia in human clinics \[[@r7]\]. However, no surveillance data are available for veterinary patients to determine which microorganism is the most common cause of pulmonary infections.

P. *aeruginosa* is notorious for its MDR characteristics and causes concern among clinicians, because it can induce a life-threatening disease in immunocompromised patients \[[@r18]\]. In the present case, we used erofloxacin and ampicillin-sulbactam for the initial treatment protocol. These antibiotics are recommended for ameliorating severe and community-acquired cases of pneumonia \[[@r10], [@r21]\]. However, the reagents we administered were ineffective against the MDR P. *aeruginosa* infection in this case. P. *aeruginosa* is often resistant to ampicillin, cephalosporin, chloramphenicol and sulphonamides \[[@r1]\]. The traditionally preferred antibiotics include ciprofloxacine, ceftazidime, aminoglycosides and carbapenem \[[@r2], [@r7], [@r18]\]. In human medicine, new anti-pseudomonal antibiotics including doripenem, ceftobiprole and sitafloxacine have been dispensed due to the increased resistance rate of P. *aeruginosa* against traditionally preferred antibiotics \[[@r7]\]. A more recent study reported that the resistance rates of P. *aeruginosa* isolated from dogs and cats against enrofloxacine, ciprofloxacine and cefotaxime were 31.5, 20.5 and 17.8%, respectively \[[@r8]\]. Another report showed that large numbers of P. *aeruginosa* isolated from canine otitis externae are resistant to enrofloxacine (51.9%) and gentamycin (43.3%) \[[@r13]\].

In the present study, we showed that tracheal washing was a safe and effective approach for making an early diagnosis of pneumonia during the initial stage of renal transplantation in canines. We demonstrated that localized pneumonia caused by MDR *P. aeruginosa* infection after renal transplantation in a dog could be treated using appropriate antibiotics according to the results of an antibiotic susceptibility test. We suggest that small animal clinicians do not need to consider reducing the dosage of immunosuppressants to treat MDR *P. aeruginosa* pneumonia during the early stage of renal transplantation in canines. However, effective management protocols for systemic MDR *P. aeruginosa*-associated complications, such as bacteremia, neutropenia and vascular dehiscence, in canine renal transplant patients should be described in future studies. Our case report provides beneficial data for establishing standardized diagnostic and therapeutic guidelines to manage MDR bacterial pneumonia in canine renal transplant patients.
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